[1]刘治昆.益肾健脾方对体外冲击波碎石术后患者疗效的影响[J].西部中医药,2025,38(01):133-135.[doi:10.12174/j.issn.2096-9600.2025.01.26]
 LIU Zhikun.Influence of Kidney-benefiting Spleen-invigorating Prescription on Clinical Effects of Patients Undergoing Extracorporeal Shockwave Lithotripsy[J].Western Journal of Traditional Chinese Medicine,2025,38(01):133-135.[doi:10.12174/j.issn.2096-9600.2025.01.26]
点击复制

益肾健脾方对体外冲击波碎石术后患者疗效的影响()
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年01期
页码:
133-135
栏目:
临床研究
出版日期:
2025-01-15

文章信息/Info

Title:
Influence of Kidney-benefiting Spleen-invigorating Prescription on Clinical Effects of Patients Undergoing Extracorporeal Shockwave Lithotripsy
作者:
刘治昆
桂林市中医医院,广西 桂林 541002
Author(s):
LIU Zhikun
Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin541002, China
关键词:
泌尿系结石体外冲击波碎石术益肾健脾方脾肾两虚证复发
Keywords:
urinary stonesextracorporeal shockwave lithotripsykidney-benefiting spleen-invigorating prescriptionspleen-kidney deficiency patternrecurrence
分类号:
R269
DOI:
10.12174/j.issn.2096-9600.2025.01.26
文献标志码:
B
摘要:
目的探讨益肾健脾方对泌尿系结石患者体外冲击波碎石(extracorporeal shockwave lithotripsy,ESWL)术后的疗效及远期复发率的影响。 方法将采取ESWL治疗的泌尿系结石患者90例,根据随机数字表法分为对照组(45例)与观察组(45例)。两组行ESWL治疗后,对照组给予盐酸坦索罗辛治疗,观察组给予益肾健脾方治疗,两组均连续用药2周。观察两组症状、体征消失时间、脾肾两虚证单项症状评分变化情况、总有效率及复发率情况。 结果观察组结石排尽、肉眼血尿消失、腰痛减轻等症状恢复时间均短于对照组(P<0.05);治疗后,两组脾肾两虚证单项症状评分降低(P<0.05),且观察组评分低于对照组(P<0.05);观察组总有效率[97.78%(44/45)]高于对照组[82.22%(37/45)](P<0.05);观察组复发率[2.22%(1/45)]低于对照组[15.56%(7/45)](P<0.05)。 结论益肾健脾方可有效辅助治疗ESWL术后泌尿系统结石患者,能促进症状、体征和中医证候的减轻,减少结石复发率。
Abstract:
ObjectiveTo discuss the clinical efficacy of kidney-benefiting spleen-invigorating prescription in the treatment of patients with urinary stones after extracorporeal shockwave lithotripsy (ESWL), and its influence on long-term recurrence rate. MethodsAll 90 patients suffering urinary stones, who will undergo ESWL, were allocated to the control group and the observation group according to random number table method with 45 cases in each group. After performing ESWL, the control group was treated with tamsulosin hydrochloride sustained release capsules, and the observation group took kidney-benefiting spleen-invigorating prescription orally, and both groups were medicated for two consecutive weeks. To observe the disappearance time of the symptoms and body signs, single symptom scores of spleen-kidney deficiency syndrome in the two groups, as well as total effective rate and the recurrence rate. ResultsThe recovery time of the symptoms including stone discharge, gross hematuria disappearing, and lumbago disappearance in the observation group was shorter than that of the control group (P<0.05); after the treatment, the scores of single symptoms of spleen-kidney deficiency pattern were lowered in the two groups (P<0.05), and the scores of the observation group were lower than these of the control group (P<0.05); total effective rate of the observation group was [97.78%(44/45)], higher than that [82.22%(37/45)] of the control group (P<0.05); the recurrence rate of the observation group was [2.22%(1/45)], lower than [15.56%(7/45)] of the control group (P<0.05). ConclusionThe prescription as adjunctive therapy could effectively treat the patients suffering urinary stones after ESWL, promote the reduction of symptoms, body signs and TCM syndromes, and reduce the recurrence rate of stones.

相似文献/References:

[1]许礼伟.中西医结合治疗泌尿系结石350例临床体会[J].西部中医药,2012,25(07):75.
 XU Li-wei.Clinical Experience on Treating 350 Cases of Urinary Stone with Integrated Traditional Chinese and Western Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(01):75.
[2]吴文弼,侯瑞鹏,温丽芳,等.超声双探头联合定位法在体外冲击波碎石术中的应用[J].西部中医药,2015,28(09):131.
[3]文晶晶,黄桂红,阳玉晶,等.自拟中药方治疗下焦湿热型泌尿系结石62例[J].西部中医药,2023,36(12):103.[doi:10.12174/j.issn.2096-9600.2023.12.22]
 WEN Jingjing,HUANG Guihong,YANG Yujing,et al.Treating 62 Cases of Urinary Calculi of Damp-heat in Lower Energizer Pattern with Self-made Chinese Medicine Prescription[J].Western Journal of Traditional Chinese Medicine,2023,36(01):103.[doi:10.12174/j.issn.2096-9600.2023.12.22]

备注/Memo

备注/Memo:
刘治昆(1980—),男,硕士学位,副主任医师。研究方向:泌尿外科疾病的中西医结合治疗。Email:gxgl120110@163.com国家自然科学基金(81061067)。
更新日期/Last Update: 2025-01-15